Retatrutide — The Triple Agonist That Is Rewriting the Rules of Weight Loss
Retatrutide — The Triple Agonist That Is Rewriting the Rules of Weight Loss 28.7% average body weight reduction. In a Phase 3 clinical trial. Over 68 weeks. To put that number in context — most bariatric surgery procedures produce average weight loss of between 25% and 30%. The most effective pharmaceutical compound previously available —…